Application of solvent influenced fluorescence-quenching and enhancement to develop a highly sensitive HPLC methodology for analysis of resveratrol-PEG conjugates

Current Pharmaceutical Analysis

Volumn 9, Issue 2, 2013, Pages 199-207

  Basavaraj, Siddalingappa ^a,d   Benson, Heather Ann Elizabeth ^a   Brown, David Havelock ^b,c   Chen, Yan ^a  

^a CURTIN UNIVERSITY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Analysis; Conjugates; Fluorescence detection; High performance liquid chromatography (HPLC); Resveratrol; Resveratrol metabolites; Resveratrol PEG

Indexed keywords

DRUG METABOLITE; METHANOL; RESVERATROL; SOLVENT;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; METHODOLOGY; MOLECULAR WEIGHT; NONHUMAN; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RAT;

EID: 84875626724     PISSN: 15734129     EISSN: 1875676X     Source Type: Journal    
DOI: 10.2174/1573412911309020011     Document Type: Article

References (27)

1. Campos-Toimil, M.; Elies, J.; Orallo, F. Trans- and cis-resveratrol increase cytoplasmic calcium levels in A7r5 vascular smooth muscle cells. Mol. Nutr. Food Res. 2005, 49, 396-404.
2. Delmas, D.; Jannin, B.; Latruffe, N. Resveratrol: preventing properties against vascular alterations and ageing. Mol. Nutr. Food Res. 2005, 49, 377-395.
3. Le Corre, L.; Chalabi, N.; Delort, L.; Bignon, Y. J.; Bernard- Gallon, D. J. Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol. Nutr. Food Res. 2005, 49, 462-471.
4. Das, D. K.; Maulik, N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol. Interv. 2006, 6, 36-47.
5. Wenzel, E.; Somoza, V. Metabolism and bioavailability of transresveratrol. Mol. Nutr. Food Res. 2005, 49, 472-481.
6. Ziegler, C. C.; Rainwater, L.; Whelan, J.; McEntee, M. F. Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Min/+) mice. J. Nutr. 2004, 134, 5-10.
7. Goldberg, D. M.; Yan, J.; Soleas, G. J. Absorption of three winerelated polyphenols in three different matrices by healthy subjects. Clin. Biochem. 2003, 36, 79-87.
8. Walle, T.; Hsieh, F.; DeLegge, M. H.; Oatis, J. E., Jr.; Walle, U. K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 2004, 32, 1377-1382.
9. Wang, D.; Hang, T.; Wu, C.; Liu, W. Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS. J. Chromatogr. B 2005, 829, 97-106.
10. Juan, M. E.; Maijo, M.; Planas, J. M. Quantification of transresveratrol and its metabolites in rat plasma and tissues by HPLC. J. Pharm. Biomed.Anal. 2010, 51, 391-398.
11. Hoshino, J.; Park, E. J.; Kondratyuk, T. P.; Marler, L.; Pezzuto, J. M.; van Breemen, R. B.; Mo, S.; Li, Y.; Cushman, M. Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J. Med. Chem. 2010, 53, 5033-5043.
12. Biasutto, L.; Marotta, E.; Mattarei, A.; Beltramello, S.; Caliceti, P.; Salmaso, S.; Bernkop-Schnurch, A.; Garbisa, S.; Zoratti, M.; Paradisi, C. Absorption and metabolism of resveratrol carboxyesters and methanesulfonate by explanted rat intestinal segments. Cell. Physiol. Biochem. 2009, 24, 557-566.
13. Pineiro, Z.; Palma, M.; Barroso, C. G. Determination of transresveratrol in grapes by pressurised liquid extraction and fast highperformance liquid chromatography. J. Chromatogr. A 2006, 1110, 61-65.
14. Lopez, R.; Dugo, P.; Mondello, L., Determination of transresveratrol in wine by micro-HPLC with fluorescence detection. J. Sep. Sci. 2007, 30, 669-672.
15. Pezet, R.; Pont, M.; Cuenat, P. Method to determine resveratrol and pterostilbene in grape berries and wines using high-performance liquid chromatography and highly sensitive fluorimetric detection. J. Chromatogr. A 1994, 663, 191-97.
16. Boocock, D. J.; Patel, K. R.; Faust, G. E.; Normolle, D. P.; Marczylo, T. H.; Crowell, J. A.; Brenner, D. E.; Booth, T. D.; Gescher, A.; Steward, W. P. Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 848, 182-187.
17. Urpi-Sarda, M.; Jauregui, O.; Lamuela-Raventos, R. M.; Jaeger, W.; Miksits, M.; Covas, M. I.; Andres-Lacueva, C. Uptake of diet resveratrol into the human low-density lipoprotein: Identification and quantification of resveratrol metabolites by liquid chromatog raphy coupled with tandem mass spectrometry. Anal. Chem. 2005, 77, 3149-3155.
18. Nascimento, T. C. F.; Casa, D. M.; Dalmolin, L. F.; Mattos, A.C.; Khalil, N. M.; Mainardes, R.M. Development and validation of an HPLC method using fluorescence detection for the quantitative determination of curcumin in PLGA and PLGA-PEG nanoparticles. Curr. Pharm. Anal. 2012, 8, 324-333.
19. Rupenthal, D I.; Green, C. R.; Alany, R.G. Evaluation of Fluorescence Resonance Energy Transfer Approaches as a Tool to Quantify the Stability of Antisense Oligodeoxynucleotides. Curr. Pharm. Anal. 2012, 8, 20-27.
20. Block, A. M.B.; Hecht, S. Poly(propylene oxide)-poly(phenylene ethynylene) block and graft copolymers. Macromolecules, 2008, 41, 3219-3227.
21. Basavaraj, S.; Benson, H. A. E.; Cruickshank, C.; Brown, D. H.; Chen, Y. Development of a liquid chromatography/mass spectrometry methodology to separate, detect, characterize and quantify PEG-resveratrol prodrugs and the conjugation reaction precursors and intermediates. Rapid Commun. Mass Spectrom. 2011, 25, 1543-1551.
22. Shantha Kumar, T.; Chawla, S.; Nachaegari, S. K.; Singh, S. K.; Srinivas, N. R. Validated HPLC analytical method with programmed wavelength UV detection for simultaneous determination of DRF-4367 and Phenol red in rat in situ intestinal perfusion study. J.Pharm. Biomed.Anal. 2005, 38, 173-179.
23. Huang, J. D.; Wang, S.; Lo, P. C.; Fong, W. P.; Ko, W. H.; Ng, D. K. P. Halogenated silicon (IV) phthalocyanines with axial poly (ethylene glycol) chains. Synthesis, spectroscopic properties, complexation with bovine serum albumin and in vitro photodynamic activities. New J. Chem. 2004, 28, 348-354.
24. Chen, C. T.; Chiang, C. L.; Lin, Y. C.; Chan, L. H.; Huang, C. H.; Tsai, Z. W.; Chen, C. T. Ortho-substituent effect on fluorescence and electroluminescence of arylamino-substituted coumarin and stilbene. Org. Lett. 2003, 5, 1261-1264.
25. Fayed, T. A.; Etaiw, S. E. D. H.; Saleh, N. Z., Micellar effects on the molecular aggregation and fluorescence properties of benzazole- derived push-pull butadienes. J. Lumin. 2006, 121, 431-440.
26. Foroozesh, M.; Hamidi, M.; Shahbazi, M.; Sahraei, M. A new facilitated solid phase extraction method for bioavailability evaluation of lisinopril in fasting healthy male volunteers. Curr. Pharm. Anal. 2012, 8, 431-439.
27. Huang, L.; Gough, P. C.; DeFelippis, M. R. Characterization of poly (ethylene glycol) and PEGylated products by LC/MS with postcolumn addition of amines. Anal. Chem. 2008, 81, 567-577.